Biosimilars
Clinical Trials
Samsung Bioepis Reports Results of Renflexis (biosimilar, infliximab) from Two
Shots: The company reported results from two real-world studies of Renflexis (infliximab-abda) in patients with IBD registered in the US Veteran Affairs Healthcare System database. Data were presented at ACG […]readmore